{"status": "Ok", "redirect_url": "https://www.globenewswire.com/news-release/2026/04/17/3276487/0/en/ORIC-Pharmaceuticals-Presents-Preclinical-Data-to-Support-the-Potential-of-Rinzimetostat-Across-Prostate-Cancer-and-in-Emerging-Resistance-Settings-at-the-2026-American-Association.html", "message": "News view counter 669635 successfully enlarged"}